High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study.

Source:http://linkedlifedata.com/resource/pubmed/id/9779704

Download in:

View as

General Info

PMID
9779704